Ketryx
PrivateLast Round
Series B
Sep 4, 2025
Total Funding Raised
$59.05M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Ketryx operates in Enterprise Software and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Series B round in September 2025.
Ketryx is a software company that provides an AI-powered compliance platform designed to automate documentation, traceability, and validation for regulated medical device software development.
Sector
Enterprise Software
Verticals
Vertical SaaS, Compliance & Risk, Quality Management, Medical Devices, RegTech
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ketryx Comparables
Compare Ketryx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Greenlight Guru | 83% | |
| Matrix One | 82% | |
| Dot Compliance | 78% |
For institutional investors. Book with your work email.
Ketryx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 4, 2025 | ||||
| Series A | Dec 5, 2023 | ||||
| Seed | Jul 6, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ketryx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gaingels | Series B |
| Ubiquity Ventures | Series B, Seed, Series A |
| The E14 Fund | Series B, Seed, Series A |
| 53 Stations | Series B |
| Transformation Capital | Series B |
| Leerink Transformation Partners | Series B |
| Lightspeed Venture Partners | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Powers 25% of the Fortune 500 MedTech market.
- Apr 21, 2026
Platform now touches the lives of 25 million patients.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- has_revenueAug 10, 2026
Ketryx Corporation reaches an estimated $6.8M in revenue in Sep '25.
For institutional investors. Book with your work email.
Ketryx Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ketryx's valuation, stock price, and market status.
Is Ketryx a public or private company?
Ketryx is a private company.
What is the current stock price of Ketryx?
Ketryx is a private company, so its shares have no public market price. Caplight tracks Ketryx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ketryx worth (valuation)?
Valuation information for Ketryx is not publicly available.
Can I buy Ketryx stock?
Ketryx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ketryx's last funding round?
Ketryx's most recent funding round was Series B on September 4, 2025.
Who are the main investors in Ketryx?
Key investors in Ketryx include Transformation Capital, Leerink Transformation Partners, Lightspeed Venture Partners, Transformation Capital.
Will Ketryx IPO soon?
No public IPO plans have been announced for Ketryx.
How can I track Ketryx secondary market activity?
Caplight tracks bids, offers, and trades in Ketryx's shares on secondary markets.